DaVita Change in Accounts Receivable 2010-2025 | DVA

DaVita change in accounts receivable for the twelve months ending June 30, 2025 was $-0.649B, a 39.94% increase year-over-year.

  • DaVita annual change in accounts receivable for 2024 was $-0.03B, a 117.27% decline from 2023.
  • DaVita annual change in accounts receivable for 2023 was $0.172B, a 216.15% decline from 2022.
  • DaVita annual change in accounts receivable for 2022 was $-0.148B, a 7.42% increase from 2021.

DaVita Change in Accounts Receivable 2010-2025 | DVA

  • DaVita annual change in accounts receivable for 2024 was $-0.03B, a 117.27% decline from 2023.
  • DaVita annual change in accounts receivable for 2023 was $0.172B, a 216.15% decline from 2022.
  • DaVita annual change in accounts receivable for 2022 was $-0.148B, a 7.42% increase from 2021.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$20B
Encompass Health (EHC)$12.3B
Elanco Animal Health (ELAN)$8.8B
Chemed (CHE)$6.6B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$4.6B
Amedisys (AMED)$3.3B
Addus HomeCare (ADUS)$2.1B
LifeStance Health (LFST)$2.1B
Astrana Health (ASTH)$1.7B
Aveanna Healthcare Holdings (AVAH)$1.6B
U.S Physical Therapy (USPH)$1.3B
Atai Life Sciences (ATAI)$1B
Pennant (PNTG)$852M
MEDIROM Healthcare Technologies (MRM)$56M
Daxor (DXR)$52M
Psychemedics (PMD)$0M